Jon A. Rowley

Jon A. Rowley, Ph.D., is the Founder and Chief Product Officer of RoosterBio Inc. Jon started RoosterBio in 2013 as part of his personal quest of having the biggest impact possible on the commercial translation of technologies that incorporate living cells, including cellular therapies, engineered tissues, and tomorrow’s medical devices. With a Ph.D. from the University of Michigan in Biomedical Engineering, Jon has authored over 35 peer-reviewed manuscripts and has 20 issued or pending patents related to biomaterials development, tissue engineering, and cellular therapy. He started his industry career at BD as a scientist and R&D manager in a Cell & Tissue Technologies group focused on applying high throughput screening technologies to cell therapy media development and tissue engineering. Jon then contributed to the clinical development of Aastrom Biosciences’ Tissue Repair Cell product, where he was Sr Manager of Process Development responsible for manufacturing process improvements and cell delivery to the patient. Jon also spent 5 years as Director of Innovation and Process Development in Lonza’s Cell Therapy CMO business.